These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34163365)

  • 1. Solving the Problem of Assessing Synergy and Antagonism for Non-Traditional Dosing Curve Compounds Using the DE/ZI Method: Application to Nrf2 Activators.
    Repash EM; Pensabene KM; Palenchar PM; Eggler AL
    Front Pharmacol; 2021; 12():686201. PubMed ID: 34163365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dr. Jekyll and Mr. Hyde: Oxidizable phenol-generated reactive oxygen species enhance sulforaphane's antioxidant response element activation, even as they suppress Nrf2 protein accumulation.
    Bauman BM; Jeong C; Savage M; Briker AL; Janigian NG; Nguyen LL; Kemmerer ZA; Eggler AL
    Free Radic Biol Med; 2018 Aug; 124():532-540. PubMed ID: 29969714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive Dose Response Models: Defining Synergy.
    Lederer S; Dijkstra TMH; Heskes T
    Front Pharmacol; 2019; 10():1384. PubMed ID: 31849651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theory of synergistic effects: Hill-type response surfaces as 'null-interaction' models for mixtures.
    Schindler M
    Theor Biol Med Model; 2017 Aug; 14(1):15. PubMed ID: 28768512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method to Assess Interactivity of Drugs with Nonparallel Concentration Effect Relationships.
    Zhao L; Au JL; Wientjes MG
    Curr Cancer Drug Targets; 2017; 17(8):735-755. PubMed ID: 28359247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult.
    Kraft AD; Johnson DA; Johnson JA
    J Neurosci; 2004 Feb; 24(5):1101-12. PubMed ID: 14762128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics of Chemically Distinct Classes of Keap1-Nrf2 Activators Identify Common and Unique Gene, Protein, and Pathway Responses In Vivo.
    Wible RS; Tran QT; Fathima S; Sutter CH; Kensler TW; Sutter TR
    Mol Pharmacol; 2018 Apr; 93(4):297-308. PubMed ID: 29367259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare and common genetic variations in the Keap1/Nrf2 antioxidant response pathway impact thyroglobulin gene expression and circulating levels, respectively.
    Matana A; Ziros PG; Chartoumpekis DV; Renaud CO; Polašek O; Hayward C; Zemunik T; Sykiotis GP
    Biochem Pharmacol; 2020 Mar; 173():113605. PubMed ID: 31421134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprint of: Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs.
    Satoh T; McKercher SR; Lipton SA
    Free Radic Biol Med; 2014 Jan; 66():45-57. PubMed ID: 24262357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model.
    Goldoni M; Johansson C
    Toxicol In Vitro; 2007 Aug; 21(5):759-69. PubMed ID: 17420112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive Dose Response Models: Explicit Formulation and the Loewe Additivity Consistency Condition.
    Lederer S; Dijkstra TMH; Heskes T
    Front Pharmacol; 2018; 9():31. PubMed ID: 29467650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in the development of small molecule Nrf2 modulators: a patent review (2012-2016).
    Sun H; Zhu J; Lin H; Gu K; Feng F
    Expert Opin Ther Pat; 2017 Jul; 27(7):763-785. PubMed ID: 28454500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells.
    Foresti R; Bains SK; Pitchumony TS; de Castro Brás LE; Drago F; Dubois-Randé JL; Bucolo C; Motterlini R
    Pharmacol Res; 2013 Oct; 76():132-48. PubMed ID: 23942037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bliss and Loewe interaction analyses of clinically relevant drug combinations in human colon cancer cell lines reveal complex patterns of synergy and antagonism.
    Kashif M; Andersson C; Mansoori S; Larsson R; Nygren P; Gustafsson MG
    Oncotarget; 2017 Nov; 8(61):103952-103967. PubMed ID: 29262612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Early Biological Effects of Isoprene-Derived Particulate Matter Enhanced by Anthropogenic Pollutants.
    Surratt JD; Lin YH; Arashiro M; Vizuete WG; Zhang Z; Gold A; Jaspers I; Fry RC
    Res Rep Health Eff Inst; 2019 Mar; 2019(198):1-54. PubMed ID: 31872748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
    Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
    Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bioactive constituents in the Traditional Chinese Medicinal formula Si-Wu-Tang on Nrf2 signaling and neoplastic cellular transformation.
    Liu MM; Huang KM; Qian L; Chatterjee P; Zhang S; Li R; Zhou S; Wang Z; Luo Y; Huang Y
    Phytomedicine; 2018 Feb; 40():1-9. PubMed ID: 29496161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interaction: focusing on response surface models.
    Lee SI
    Korean J Anesthesiol; 2010 May; 58(5):421-34. PubMed ID: 20532049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present).
    Zhou H; Wang Y; You Q; Jiang Z
    Expert Opin Ther Pat; 2020 Mar; 30(3):209-225. PubMed ID: 31922884
    [No Abstract]   [Full Text] [Related]  

  • 20. Fitting models for the joint action of two drugs using SAS.
    Whitehead A; Whitehead J; Todd S; Zhou Y; Smith MK
    Pharm Stat; 2008; 7(4):272-84. PubMed ID: 17979217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.